Figure 2A shows the expression profiles of 35 known lncRNAs in each cell sample. The top 10 lncRNAs were selected for qPCR validation. As shown in Figures 2B, C, six lncRNAs (LINC00278, LINC02848, LINC00844, B3GALT5-AS1, LINC00657, and LINC00852) were significantly altered in T2DM-BMSCs (p < 0.05), and UNC0638 treatment caused significant upregulation of LINC00278 and LINC00657 [also known as NORAD (43)] (p < 0.05). This evidence concerns the gene B3GALT5 and type 2 diabetes mellitus.